Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Cancer Genetics

Researchers' work adds to cancer genetics body of knowledge

Study 1: A study from the Netherlands suggests that breast tumor development pathways may differ between BRCA1- and BRCA2-related cancers.

"BRCA1 or BRCA2 germline mutations cause [about] 30% of breast cancers within high-risk families. This represents 5% of total breast cancer incidence. Although BRCA1 and BRCA2 are both implicated in DNA repair and genome stability, it is unknown whether BRCA1 and BRCA2 are associated with similar or distinct diseases," said E.H. van Beers and colleagues at the Netherlands Cancer Institute, Amsterdam.

...

• View Other Issues of Women's Health Weekly
  
• View Other NewsRx Publications